CTMX
CytomX Therapeutics Inc
2.80$
+2.2%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +51.9% | +95.1% | +376.1% | -16.9% | -3.4% | +19.0% | +1.7% | -23.6% | +90.4% | +36.4% | -44.8% | |
| – | +16.6% | +83.6% | +44.8% | -100.0% | – | – | – | +0.3% | -62.9% | -18.7% | – | |
| – | +51.9% | +95.1% | +376.1% | -16.9% | -3.4% | +19.0% | +1.7% | -23.6% | +90.4% | +36.4% | -44.8% | |
| – | +0.2% | +93.1% | +68.5% | +12.6% | +26.7% | -14.2% | +1.1% | -2.2% | -30.4% | +7.3% | -17.6% | |
| – | +92.0% | +58.3% | +28.8% | +30.9% | +9.7% | -2.0% | +8.7% | +9.4% | -29.9% | -1.0% | +0.4% | |
| – | +17.4% | +82.4% | +58.0% | +16.5% | +22.6% | -11.5% | +2.9% | +0.7% | -30.3% | +5.0% | -12.9% | |
| – | – | – | – | – | – | – | – | – | – | – | -189.5% | |
| – | +255.6% | -2.5% | -100.0% | – | – | -83.3% | -90.5% | +1,073.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +865.8% | -153.4% | |
| – | +0.0% | -290.0% | – | – | -103.0% | – | -121.3% | – | – | -94.2% | +6.3% | |
| – | – | – | – | – | – | – | – | – | – | – | -154.5% | |
| – | – | – | – | – | – | – | – | – | – | +515.9% | -146.5% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.